GHCL Ltd
GHCL Ltd
ChemicalsKey Fundamentals
MicrocapCommodity ChemicalsChemicalsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view GHCL Ltd insights
48 extracted metrics + investor summaries across FY12–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
4- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 1.14 times its book value
- Company has been maintaining a healthy dividend payout of 18.7%
Weaknesses
2- The company has delivered a poor sales growth of 4.23% over past five years.
- Promoter holding is low: 19.8%
Growth Rate
AI Analysis — Bull vs Bear
GHCL Ltd trades at a PE of 8.6x and 1.14x book value with a market cap of Rs 4,080 crore, reflecting a nearly debt-free balance sheet but declining profitability with TTM profit down 24% and sales down 4%. The stock has corrected 26% over the past year amid weakening operating performance despite historically strong return ratios.
- Company is almost debt-free, having significantly reduced leverage, which lowers financial risk and interest burden
- Valuation appears undemanding at PE of 8.6x, well below broader market multiples for chemical sector peers
- Trading at just 1.14x book value, offering limited downside from an asset-backing perspective
- Healthy dividend yield of 2.73% with a consistent payout ratio of 18.7%, providing income support during stock weakness
- 5-year ROE average of 21% and 10-year ROE of 21% demonstrate historically strong capital efficiency and earning power
- 5-year compounded profit growth of 7% and 10-year profit CAGR of 6% show long-term earnings have grown despite recent weakness
- 10-year stock CAGR of 7% indicates the business has created shareholder value over longer time horizons despite recent correction
- TTM compounded profit declined 24% year-over-year, signalling significant near-term earnings deterioration
- 3-year compounded profit CAGR of -25% indicates a sustained multi-year earnings decline, not just a one-off
- Sales have contracted with TTM revenue down 4% and 3-year sales CAGR of -12%, reflecting structural demand or pricing headwinds
- ROE has deteriorated from 21% (5-year average) to just 13% in the last year, a sharp drop in capital efficiency
- Promoter holding is low at 19.8%, which raises governance concerns and limits promoter alignment with minority shareholders
- Poor 5-year sales growth of only 4.23% indicates limited top-line expansion capability in the soda ash business
- Stock has declined 26% over the past year and 7% CAGR decline over 3 years, reflecting persistent negative market sentiment
- 1-year stock decline of 26% far exceeds broader market returns, suggesting company-specific challenges beyond sector weakness
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Q1FY27 earnings call scheduled Jul 26
GHCL scheduled a conference call on August 3, 2026 at 3:00 PM IST to discuss Q1FY27 results with MD R S Jalan and CFO Raman Chopra.
TL;DR: Limited recent news flow for GHCL with only a routine earnings call announcement. No identifiable headwinds or positive catalysts in the current news cycle. Investors should watch the August 3 Q1FY27 results for clarity on the company's chemical segment performance and forward guidance.
Quarterly Results
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,120 | 1,019 | 805 | 798 | 823 | 830 | 793 | 779 | 781 | 796 | 721 | 757 | 791 |
| Expenses | 771 | 719 | 592 | 648 | 639 | 614 | 582 | 549 | 563 | 599 | 564 | 598 | 615 |
| Operating Profit | 349 | 299 | 213 | 150 | 184 | 217 | 211 | 230 | 218 | 197 | 157 | 159 | 176 |
| OPM % | 31% | 29% | 26% | 19% | 22% | 26% | 27% | 30% | 28% | 25% | 22% | 21% | 22% |
| Other Income | -3 | 230 | 11 | 14 | 17 | 18 | 17 | 29 | 23 | 27 | 17 | 16 | 14 |
| Interest | 10 | 8 | 7 | 6 | 5 | 4 | 4 | 4 | 4 | 2 | 2 | 3 | 2 |
| Depreciation | 27 | 24 | 26 | 26 | 26 | 27 | 28 | 28 | 28 | 27 | 28 | 29 | 27 |
| PBT | 309 | 497 | 191 | 133 | 170 | 203 | 196 | 227 | 209 | 195 | 145 | 143 | 160 |
| Tax % | 27% | 14% | 25% | 25% | 26% | 26% | 21% | 26% | 28% | 26% | 26% | 26% | 28% |
| Net Profit | 227 | 426 | 143 | 100 | 125 | 151 | 155 | 168 | 150 | 144 | 107 | 106 | 116 |
| EPS in Rs | 23.7 | 44.6 | 14.94 | 10.43 | 13.04 | 15.73 | 16.17 | 17.59 | 15.69 | 15 | 11.11 | 11.53 | 12.58 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,356 | 2,531 | 2,784 | 2,919 | 3,341 | 3,305 | 2,491 | 3,052 | 4,551 | 3,447 | 3,183 | 3,064 |
| Expenses | 1,828 | 1,901 | 2,103 | 2,313 | 2,582 | 2,576 | 1,886 | 2,322 | 3,048 | 2,596 | 2,306 | 2,375 |
| Operating Profit | 528 | 629 | 681 | 607 | 759 | 729 | 605 | 730 | 1,503 | 851 | 877 | 690 |
| OPM % | 22% | 25% | 24% | 21% | 23% | 22% | 24% | 24% | 33% | 25% | 28% | 22% |
| Other Income | -15 | -3 | 37 | 38 | 16 | 16 | 18 | 211 | 119 | 270 | 88 | 73 |
| Interest | 171 | 165 | 137 | 127 | 127 | 120 | 74 | 51 | 39 | 27 | 17 | 10 |
| Depreciation | 85 | 82 | 86 | 110 | 117 | 131 | 111 | 87 | 94 | 102 | 112 | 111 |
| PBT | 257 | 380 | 495 | 407 | 531 | 495 | 437 | 802 | 1,489 | 991 | 836 | 642 |
| Tax % | 29% | 32% | 23% | 13% | 34% | 20% | 25% | 19% | 23% | 20% | 25% | 26% |
| Net Profit | 182 | 258 | 380 | 356 | 351 | 397 | 326 | 650 | 1,142 | 794 | 624 | 472 |
| EPS in Rs | 18.19 | 25.78 | 38.04 | 36.59 | 35.77 | 41.75 | 34.33 | 68.14 | 119 | 82.94 | 65.18 | 51.39 |
| Div. Payout % | 12% | 0% | 13% | 14% | 14% | 7% | 16% | 22% | 15% | 14% | 18% | 23% |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 100 | 100 | 99 | 97 | 98 | 95 | 95 | 95 | 96 | 96 | 96 | 92 |
| Reserves | 670 | 936 | 1,247 | 1,513 | 1,827 | 2,054 | 2,389 | 2,852 | 3,860 | 2,883 | 3,393 | 3,460 |
| Borrowings | 1,324 | 1,365 | 1,463 | 1,322 | 1,302 | 1,254 | 782 | 788 | 361 | 210 | 119 | 83 |
| Other Liabilities | 758 | 548 | 694 | 695 | 767 | 766 | 712 | 1,261 | 816 | 581 | 578 | 665 |
| Total Liabilities | 2,851 | 2,949 | 3,504 | 3,628 | 3,995 | 4,169 | 3,978 | 4,995 | 5,133 | 3,770 | 4,185 | 4,300 |
| Fixed Assets | 1,934 | 2,049 | 2,410 | 2,502 | 2,591 | 2,664 | 2,675 | 2,474 | 1,731 | 1,842 | 1,844 | 1,821 |
| CWIP | 7 | 37 | 26 | 74 | 117 | 122 | 81 | 213 | 109 | 55 | 256 | 450 |
| Investments | 2 | 15 | 9 | 10 | 12 | 9 | 15 | 17 | 380 | 420 | 651 | 1,042 |
| Other Assets | 909 | 848 | 1,059 | 1,043 | 1,275 | 1,375 | 1,207 | 2,292 | 2,914 | 1,453 | 1,435 | 987 |
| Total Assets | 2,851 | 2,949 | 3,504 | 3,628 | 3,995 | 4,169 | 3,978 | 4,995 | 5,133 | 3,770 | 4,185 | 4,300 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 416 | 509 | 458 | 590 | 530 | 624 | 621 | 643 | 856 | 797 | 638 | 687 |
| Investing | -127 | -249 | -375 | -279 | -271 | -206 | -109 | -337 | -409 | -534 | -358 | -291 |
| Financing | -296 | -252 | -113 | -308 | -258 | -339 | -569 | -98 | -530 | -338 | -230 | -451 |
| Net Cash Flow | -8 | 8 | -30 | 2 | 1 | 80 | -57 | 209 | -83 | -75 | 50 | -55 |
| Free Cash Flow | 284 | 258 | 82 | 308 | 257 | 418 | 510 | 306 | 506 | 691 | 336 | 424 |
| CFO/OP | 91 | 96 | 83 | 109 | 82 | 101 | 120 | 116 | 86 | 116 | 98 | 124 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 38 | 26 | 36 | 29 | 32 | 30 | 33 | 27 | 18 | 19 | 24 | 21 |
| Inventory Days | 193 | 194 | 187 | 182 | 199 | 198 | 245 | 294 | 177 | 185 | 217 | 199 |
| Days Payable | 155 | 110 | 107 | 109 | 106 | 102 | 121 | 107 | 53 | 55 | 57 | 94 |
| Cash Conversion Cycle | 76 | 110 | 117 | 101 | 125 | 126 | 158 | 214 | 142 | 149 | 183 | 126 |
| Working Capital Days | -39 | -48 | -30 | -12 | 10 | 26 | 61 | 87 | 50 | 50 | 58 | 43 |
| ROCE % | 22% | 25% | 24% | 19% | 21% | 19% | 15% | 19% | 36% | 21% | 24% | 17% |
Documents
Frequently Asked Questions about GHCL Ltd
What does GHCL Ltd do?
Where is GHCL Ltd (GHCL) listed?
Which sector does GHCL Ltd belong to?
What is the market capitalisation of GHCL Ltd?
What is the PE ratio of GHCL Ltd?
What is the 52-week high and low of GHCL Ltd?
Does GHCL Ltd pay dividends?
What is the Return on Equity (ROE) of GHCL Ltd?
How can I research GHCL Ltd on Tapetide?
Company Information
Established 1983, GHCL Limited is engaged in the business of manufacturing and trading of Inorganic Chemicals (Soda Ash).[1][2]